iifl-logo

Most Read News

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

Rana Sugars Limited has informed the Exchange about appointment of RANA INDER PRATAP SINGH as Compliance Officer of the company w.e.f. 18-Nov-2022

image

PTC India Financial Services Limited has informed the Exchange about Investor Presentation

image

Arshiya Limited has informed the Exchange about Notice of Postal Ballot, In continuation to our letter dated 14th November, 2022 regarding outcome of Board Meeting and pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Postal Ballot Notice for seeking approval of Shareholders of the Company by way of Special Resolution for the business as set out in the Postal Ballot Notice. Remote e-voting period shall commence on Sunday, November 20, 2022 (9:00 A.M. IST) and end on Monday, December 19, 2022 (5.00 P.M. IST) (both days inclusive). The results of the remote e-voting shall be announced on or before Tuesday, December 20, 2022 and the same will be communicated to the Stock Exchanges along with the Scrutinizers report within the prescribed time. The Postal Ballot Notice is also available on the website of the Company. This is for your information as also for the information of public at large.

image

INEOS Styrolution India Limited has informed the Exchange about appointment of Ravishankar Kompalli as Executive Director of the company w.e.f. 17-Nov-2022

image

Aurobindo Pharma Limited is pleased to announce that its wholly owned subsidiary company, Eugia Pharma Specialities Limited, has received a final approval from the US Food & Drug Administration (USFDA) for Amphotericin B Liposome for Injection, 50 mg. Amphotericin B Liposome for Injection, 50 mg/vial Single-Dose Vial to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), AmBisome Liposome for Injection, 50 mg/vial, of Astellas Pharma US, Inc.. The product is expected to be launched by Q4 FY23. The approved product has an estimated market size of around US$ 145 million for the twelve months ending September 2022, according to IQVIA.

image

Bharat Petroleum Corporation Limited has informed the Exchange about Voting results and Scrutinizer report of Postal Ballot

image

MRF Limited has informed the Exchange about Notice of Postal Ballot

image

Sun Pharmaceutical Industries Limited has informed the Exchange about press release dated 18-Nov-2022 titled SEZABY??? phenobarbital sodium powder for injection) approved by US FDA for the treatment of neonatal seizures

image

Mcnally Bharat Engineering Company Limited has informed the Exchange about Minutes of Annual General Meeting held on 07-Sep-2022

image

Chaman Lal Setia Exports Limited has informed the Exchange about Upgrade of Credit Rating

Image
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.